Sign inJoin waitlistJoin the waitlist

Jamie Buryanek

Associate Professor · University of Texas Health Science Center at Houston

Credentials: · · · ·

History

University of Texas Health Science Center at Houston
Present

Methodist Hospital TMC
2007–2008
UTHSC at Houston
2006–2007
Methodist Hospital TMC
2005–2006
Pathology
University of Kansas School of Medicine
2001–2005
University of South Dakota Sanford School of Medicine
1997–2001

Research

Targeting the apoptotic pathway in chondrosarcoma using recombinant human Apo2L/TRAIL (dulanermin), a dual proapoptotic receptor (DR4/DR5) agonist
Molecular Cancer Therapeutics · 2012 · 56 citations
Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms'…
Case report · PLoS ONE · 2013 · 38 citations
Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and…
Case report · Oncoscience · 2016 · 33 citations

Ron Karni
3 papers
Vivek Subbiah
3 papers · 1 as a fellow
Adan Rios
2 papers
Angel Blanco
2 papers
JW
Johannes Wolff
2 papers
Pushan Jani
2 papers
Razelle Kurzrock
2 papers
RH
Richard Huang
2 papers · 2 as a resident
RB
Robert Brown
2 papers
SG
Shan Guo
2 papers
AA
Ali Al-Habib
1 paper · 1 as a fellow
AY
Anas Younes
1 paper